Asymmetric dimethylarginine levels in thyroid diseases

Journal of Endocrinological Investigation

Volumn 30, Issue 3, 2007, Pages 186-191

  Arikan, E ^a   Karadag, C H ^a   Guldiken, S ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

ADMA; Endothelial dysfunction; Hyperthyroidism; Hypothyroidism; L arginine; SDMA

Indexed keywords

ARGININE; CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOARGININE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; THYROTROPIN; THYROXINE;

ADULT; AGE; AMINO ACID METABOLISM; AMINO ACID TRANSPORT; ARTICLE; AUTOIMMUNE THYROIDITIS; BLOOD SAMPLING; COMPETITIVE INHIBITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENZYME INHIBITION; FEMALE; GRAVES DISEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; THYROID DISEASE; TOXIC GOITER;

EID: 34250639044     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347423     Document Type: Article

References (23)

1. Vargas F, Moreno JM, Rodriguez-Gomez I, et al. Vascular and renal function in experimental thyroid disorders. Eur J Endocrinol 2006, 154: 197-212.
2. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989, 3: 2007-18.
3. Forstermann U, Closs EI, Pollock JS, et al. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension 1994, 23: 1121-31.
4. Napoli R, Biondi B, Guardasole V, et al. Impact of hyperthyroidism and its correction on vascular reactivity in humans. Circulation 2001, 104: 3076-80.
5. Papaioannou GI, Lagasse M, Mather JF, Thompson PD. Treating hypothyroidism improves endothelial function. Metabolism 2004, 53: 278-9.
6. Lekakis J, Papamichael C, Alevizaki M, et al. Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid 1997, 7: 411-4.
7. Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 2000, 20: 2032-7.
8. Hermenegildo C, Medina P, Peiro M, et al. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitorof nitric oxide synthase, is elevated in hyperthyroid patients. J Clin Endocrinol Metab 2002, 87: 5636-40.
9. Ozcan O, Cakir E, Yaman H, et al. The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism. Clin Endocrinol (Oxf) 2005, 63: 203-6.
10. Teerlink T, Nijveldt RJ, de Jong S, van Leeuwen PA. Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 2002, 303: 131-7.
11. Boger RH, Sydow K, Borlak J, et al. LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Circ Res 2000, 87: 99-105.
12. Leiper J, Murray-Rust J, McDonald N, Vallance P. S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase. Proc Natl Acad Sci USA 2002, 99: 13527-32.
13. Sarandol E, Tas S, Dirican M, Serdar Z. Oxidative stress and serum paraoxonase activity in experimental hypothyroidism: effect of vitamin E supplementation. Cell Biochem Funct 2005, 23: 1-8.
14. Dariyerli N, Toplan S, Akyolcu MC, Hatemi H, Yigit G. Erythrocyte osmotic fragility and oxidative stress in experimental hypothyroidism. Endocrine 2004, 25: 1-5.
15. Tenorio-Velazquez VM, Barrera D, Franco M, et al. Hypothyroidism attenuates protein tyrosine nitration, oxidative stress and renal damage induced by ischemia and reperfusion: effect unrelated to antioxidant enzymes activities. BMC Nephrol 2005, 6:12.
16. Yilmaz S, Ozan S, Benzer F, Canatan H. Oxidative damage and antioxidant enzyme activities in experimental hypothyroidism. Cell Biochem Funct 2003, 21: 325-30.
17. Konukoglu D, Ercan M, Hatemi H. Plasma viscosity in female patients with hypothyroidism: effects of oxidative stress and cholesterol. Clin Hemorheol Microcirc 2002, 27: 107-13.
18. Miyazaki H, Matsuoka H, Cooke JP, et al. [Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis]. J Cardiol 1999, 33: 105-6.
19. Eid HM, Arnesen H, Hjerkinn EM, Lyberg T, Seljeflot I. Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine. Metabolism 2004, 53: 1574-9.
20. Krzyzanowska K, Mittermayer F, Kopp HP, Wolzt M, Schernthaner G. Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women. J Clin Endocrinol Metab 2004, 89: 6277-81.
21. Goonasekera CD, Rees DD, Woolard P, et al. Nitric oxide synthase inhibitors and hypertension in children and adolescents. J Hypertens 1997, 15: 901-9.
22. Boger RH, Bode-Boger SM, Szuba A, et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 1998, 98: 1842-7.
23. Bode-Boger SM, Scalera F, Kielstein JT, et al. Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease. J Am Soc Nephrol 2006, 17: 1128-34.